Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Permeability Barrier and Microstructure of Skin Lipid Membrane Models of Impaired Glucosylceramide Processing

M. Sochorová, K. Staňková, P. Pullmannová, A. Kováčik, J. Zbytovská, K. Vávrová,

. 2017 ; 7 (1) : 6470. [pub] 20170725

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19013116

Ceramide (Cer) release from glucosylceramides (GlcCer) is critical for the formation of the skin permeability barrier. Changes in β-glucocerebrosidase (GlcCer'ase) activity lead to diminished Cer, GlcCer accumulation and structural defects in SC lipid lamellae; however, the molecular basis for this impairment is not clear. We investigated impaired GlcCer-to-Cer processing in human Cer membranes to determine the physicochemical properties responsible for the barrier defects. Minor impairment (5-25%) of the Cer generation from GlcCer decreased the permeability of the model membrane to four markers and altered the membrane microstructure (studied by X-ray powder diffraction and infrared spectroscopy), in agreement with the effects of topical GlcCer in human skin. At these concentrations, the accumulation of GlcCer was a stronger contributor to this disturbance than the lack of human Cer. However, replacement of 50-100% human Cer by GlcCer led to the formation of a new lamellar phase and the maintenance of a rather good barrier to the four studied permeability markers. These findings suggest that the major cause of the impaired water permeability barrier in complete GlcCer'ase deficiency is not the accumulation of free GlcCer but other factors, possibly the retention of GlcCer bound in the corneocyte lipid envelope.

000      
00000naa a2200000 a 4500
001      
bmc19013116
003      
CZ-PrNML
005      
20190405092908.0
007      
ta
008      
190405s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-017-06990-7 $2 doi
035    __
$a (PubMed)28744000
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Sochorová, Michaela $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy, Hradec Králové, 500 05, Czech Republic.
245    10
$a Permeability Barrier and Microstructure of Skin Lipid Membrane Models of Impaired Glucosylceramide Processing / $c M. Sochorová, K. Staňková, P. Pullmannová, A. Kováčik, J. Zbytovská, K. Vávrová,
520    9_
$a Ceramide (Cer) release from glucosylceramides (GlcCer) is critical for the formation of the skin permeability barrier. Changes in β-glucocerebrosidase (GlcCer'ase) activity lead to diminished Cer, GlcCer accumulation and structural defects in SC lipid lamellae; however, the molecular basis for this impairment is not clear. We investigated impaired GlcCer-to-Cer processing in human Cer membranes to determine the physicochemical properties responsible for the barrier defects. Minor impairment (5-25%) of the Cer generation from GlcCer decreased the permeability of the model membrane to four markers and altered the membrane microstructure (studied by X-ray powder diffraction and infrared spectroscopy), in agreement with the effects of topical GlcCer in human skin. At these concentrations, the accumulation of GlcCer was a stronger contributor to this disturbance than the lack of human Cer. However, replacement of 50-100% human Cer by GlcCer led to the formation of a new lamellar phase and the maintenance of a rather good barrier to the four studied permeability markers. These findings suggest that the major cause of the impaired water permeability barrier in complete GlcCer'ase deficiency is not the accumulation of free GlcCer but other factors, possibly the retention of GlcCer bound in the corneocyte lipid envelope.
650    _2
$a aplikace lokální $7 D000287
650    12
$a permeabilita buněčné membrány $x účinky léků $7 D002463
650    _2
$a ceramidy $x metabolismus $7 D002518
650    _2
$a elektrická impedance $7 D017097
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glukosylceramidy $x aplikace a dávkování $x metabolismus $x farmakologie $7 D005963
650    _2
$a lidé $7 D006801
650    _2
$a indomethacin $x farmakokinetika $7 D007213
650    _2
$a membránové lipidy $x chemie $x metabolismus $7 D008563
650    _2
$a permeabilita $7 D010539
650    _2
$a kůže $x chemie $x účinky léků $x metabolismus $7 D012867
650    _2
$a spektroskopie infračervená s Fourierovou transformací $7 D017550
650    _2
$a theofylin $x farmakokinetika $7 D013806
650    _2
$a difrakce rentgenového záření $7 D014961
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Staňková, Klára $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy, Hradec Králové, 500 05, Czech Republic.
700    1_
$a Pullmannová, Petra $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy, Hradec Králové, 500 05, Czech Republic.
700    1_
$a Kováčik, Andrej $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy, Hradec Králové, 500 05, Czech Republic.
700    1_
$a Zbytovská, Jarmila $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Hradec Králové, 500 05, Czech Republic. Department of Organic Technology, University of Chemistry and Technology Prague, 166 28, Prague, Czech Republic.
700    1_
$a Vávrová, Kateřina $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy, Hradec Králové, 500 05, Czech Republic. katerina.vavrova@faf.cuni.cz.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. 1 (2017), s. 6470
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28744000 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190405092917 $b ABA008
999    __
$a ok $b bmc $g 1392426 $s 1051421
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 7 $c 1 $d 6470 $e 20170725 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...